EP0148725A1 — Sulfonamido-benzamide derivatives
Assigned to Shionogi and Co Ltd · Expires 1985-07-17 · 41y expired
What this patent protects
Sulfonamido-benzamides which have potent antiviral and anti-occidial activities with low toxicity and compositions containing them used in prophylaxis or treatment of viral infections diseases or coccidiosis are provided. …<??>These sulfonamido-benzamides have the following…
USPTO Abstract
Sulfonamido-benzamides which have potent antiviral and anti-occidial activities with low toxicity and compositions containing them used in prophylaxis or treatment of viral infections diseases or coccidiosis are provided. …<??>These sulfonamido-benzamides have the following formula …<CHEM>… wherein R<1> is alkyl, phenyl, dialkylamino, or 5-or 6- membered heterocyclic residue; R<2> is hydrogen, alkyl, or phthalidyl; R<3> is hydrogen, halogen, alkyl, or alkoxy; R<4> is alkyl which may be substituted by 1 or 2 phenyl or furyl groups, cycloalkyl, phenyl which may have a condensed benzene ring or 1 or 2 substituents, or 5- or 6- membered heterocyclic residue; and R<5> is hydrogen or alkyl.
Drugs covered by this patent
- Zelboraf (vemurafenib) · Hoffmann La Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.